Fig. 2From: Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemiaTime to next treatment (TTNT): Kaplan–Meier curves of time to next treatment, stratified by treatment regimenBack to article page